Ok I have watched the latest interview and all I can say is wow...

Ok I have watched the latest interview and all I can say is wow if I was positive before you can times that by 3 to 5 times.
And why I say 3 to 5 times is  because that's the amount pharma can possibly use to apply our buyout price.  
now I did know about that before and now I have applied new calculations to a potential buyout CARDIO PROTECTION ONLY.
you can see this is in US currency and we have a price of $5 to $8 BILLION
View attachment 6236442
Now you can see the conversion rate currently this will change overtime

Now I have uses the lowest amount and with the 50% discount that was applied by the triangle report.
And I have even made the calculation on $7 billion flat not $7.5 /$7.6 billion so even more of a haircut
We will have under 200 mill shares on issue but I'll be using 200 mill for calculations.  
$7 bill divided by 200 m =$35 share price now that's without peak sales if we add peak sales this will be the price
3 x = $105 share price ............................
4 x = $140 share price.............................
5 x = $175 share price...............................
Now that's at the bottom end with more than a 50% discount.
If we add full price and still going on the bottom end of evaluation you have
$210 a share............................................
$280 a share ...........................................
$350 a share ............................................
So in all that my target of $30 is really a kick in the nuts for what the real potential of it could be,
Sure the longer we hold off the more we can get but we are not doing that we want to be taken over sooner so I'll leave RAC determine the best outcome for us.
Wow I'm happy hope it all goes to plan.